Skip to search formSkip to main contentSkip to account menu

Gout flare

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.
OBJECTIVE To evaluate the efficacy and safety of IL-1 inhibitor rilonacept (IL-1 Trap) for gout flare (GF) prevention during… 
2013
2013
FRI0399 Rilonacept for GOUT flare prevention in patients initiating uric acid-lowering therapy: Efficacy in patient subpopulations
Background The IL-1 antagonist rilonacept demonstrated efficacy for gout flare (GF) prevention in patients (pts) initiating uric… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)